Reaction
Band Sensation reporting signals
As of the last recalculation, Band Sensation appears in 1,261 FAERS reports alongside 22 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 66.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 73 | 66.1 | 66.3 |
| Dimenhydrinate | 31 | 49.2 | 49.3 |
| Ofatumumab | 91 | 48.6 | 48.8 |
| Teriflunomide | 96 | 37.8 | 37.9 |
| Diroximel Fumarate | 26 | 36.7 | 36.8 |
| Cimetidine | 20 | 34.8 | 34.9 |
| Siponimod | 16 | 30.0 | 30.0 |
| Dimethyl Fumarate | 175 | 27.1 | 27.1 |
| Natalizumab | 220 | 24.0 | 24.0 |
| Fingolimod Hcl | 101 | 20.9 | 20.9 |
| Cladribine | 11 | 19.0 | 19.1 |
| Interferon Beta-1B | 21 | 18.4 | 18.4 |
| Ocrelizumab | 64 | 17.9 | 17.9 |
| Peginterferon Beta-1A | 14 | 17.8 | 17.8 |
| Baclofen | 81 | 16.5 | 16.5 |
| Glatiramer Acetate | 57 | 16.4 | 16.5 |
| Interferon Beta-1A | 163 | 15.8 | 15.9 |
| Dalfampridine | 55 | 13.2 | 13.2 |
| Oxaliplatin | 54 | 12.5 | 12.5 |
| Modafinil | 24 | 12.5 | 12.5 |
| Rifampicin | 7 | 11.5 | 11.5 |
| Ravulizumab | 4 | 4.9 | 4.9 |